Glutamate in the brain is mainly cleared by GLT-1, but GLT-1 shows dysfunction or decreased expression in patients with neurodegenerative diseases such as PD [26], AD [27], or ALS [17]. This evidence concerns the gene SLC1A2 and Alzheimer disease.